Aspire Biopharma Holdings (ASBP) Times Interest Earned (2024 - 2026)
Aspire Biopharma Holdings' (ASBP) quarterly Times Interest Earned came in at -$1.03 in Q1 2026, up 98.08% year-on-year from -$0.52 in Q1 2025, and down 247.79% on a QoQ basis from -$0.3 in Q4 2025.
Aspire Biopharma Holdings (ASBP) Times Interest Earned (2024 - 2026) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has 3 years of Times Interest Earned data on file, last reported at -$1.03 in Q1 2026.
- On a quarterly basis, Times Interest Earned rose 98.08% year-over-year to -$1.03 in Q1 2026; TTM through Mar 2026 was -$2.05, a N/A change from a year earlier, with the FY2025 full-year figure at -$2.27, down 67.02% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$1.03, down from -$0.3 in the prior quarter.
- Over the last five years, Times Interest Earned for ASBP reached as high as $9.26 in Q4 2024 and fell as low as -$53.66 in Q1 2025.
- Historically, Times Interest Earned has averaged -$9.3 across 3 years, with a median of -$0.77 in 2025.
- Across the five-year window, Times Interest Earned slumped 103.2% in 2025 and jumped 98.08% in 2026, its largest moves.
- Year by year, Times Interest Earned stood at $9.26 in 2024, then slumped by 103.2% to -$0.3 in 2025, then tumbled by 247.79% to -$1.03 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$1.03 in Q1 2026, -$0.3 in Q4 2025, and -$0.77 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -0.38 |
| 10 | Aspire Biopharma Holdings | 1.09 Mn | -733,865.14 | 5,750.00 | -1.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.03 |
| Dec 31, 2025 | -0.30 |
| Sep 30, 2025 | -0.77 |
| Mar 31, 2025 | -53.66 |
| Dec 31, 2024 | 9.26 |